Clinical effects of treatment with omalizumab in patients with asthma

Not Applicable

• Conditions: Bronchial asthma

• Registration Number: JPRN-UMIN000002765
• Lead Sponsor: Atami Hospital International University of Health and Welfare

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-11-13
• Study Completion: 2011-10-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients have hypersensitivity to omalizumab 2) Pregnancy or lactation 3) Patients judged to be inappropriate by doctors

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Indices of chest CT

Secondary Outcome Measures

Name	Time	Method
Parameters of pulmonary function Cell counts of induced sputum Scores of quality of life